Oj oj oj vad ni är duktiga i USA att styra utveckling och pengar!
Varför är vi inte det i Sverige?
Är det gammeldaxa systemen med riskpengar från stiftelser och
statliga byrokratiska organisationer fel (jag nämner inga namn)?
Forskar vi på rätt saker eller springer man och leter finnansieringar
på högskolor och universitet?
Vi har fortfarande ingen "politiker" som vårdar producerande företag
i Sverige tycker jag. Vi måste vårda och serva våra producerande
företag.
MVH GÖran Wikingson
http://www.atp.nist.gov/atp/secy_rept/report.pdf
The Department of Commerce's Advanced Technology Program1 (ATP) was
authorized in 1988 and first funded in 1990. Its goal is to fund
early-stage, high-risk research that would likely be deferred if not
for government support—research with the potential to engender broad
economic benefit, not simply to benefit individual award recipients.
By assisting in the funding of this kind of research, ATP helps
propel promising technologies through the "Valley of Death"2 that
many argue is encountered by entities attempting to move new
technologies out of the laboratory and into the marketplace.
Throughout its history, ATP has remained controversial. Some critics
have suggested that the Program is an example of "corporate welfare,"
in that it funds firms, especially large firms, that seem to have the
resources to engage in the research independently. Others have
suggested that the Program funds research tasks that are too close to
product development. Late-stage research is an activity the
Administration believes should be left to the private sector. Ongoing
debates over the Program's aims and policies have hindered its
stability. Perhaps the most comprehensive study3 of the Program to
date was released by the National Research Council (NRC). The NRC
study, which addresses these controversies, found that the Program is
effective, supports research that is unlikely to be funded by the
private sector alone, and credibly assesses its record of
achievements in order to evaluate its impact. ATP funding has had a
beneficial impact, and basic research continues to be a priority for
federal investment in science and technology. The ATP Program, with
appropriate reforms, can play a useful role in the Federal science
and technology portfolio.